Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Novus Medical Detox Center Addresses Workplace Implications of Federal Medical Marijuana Ban Ending
  • USA - English


News provided by

JoTo PR

Feb 23, 2015, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Novus addresses how the federal medical marijuana ban may impact substance abuse in the workplace.
Novus addresses how the federal medical marijuana ban may impact substance abuse in the workplace.
Youtube
Youtube

Given that marijuana has been shown to have a negative impact on job performance and safety, employers have a legitimate concern regarding its use in the workplace.

Post this

New Port Richey, FL (PRWEB) February 23, 2015 -- Employers’ policies regarding workplace drug testing and employees’ cannabis use have recently fallen under question since Congress voted to end the federal ban on medical marijuana in December. In light of those questions, Novus Medical Detox Center analyzes the workplace implications of the policy change. The Florida drug detox facility emphasizes that under current law in most states, employers are still allowed to conduct drug testing and make hiring and firing decisions based on the results—regardless of whether a worker has a valid prescription for medical marijuana.

While the provision passed by Congress prohibits federal agents from prosecuting individuals who are buying or selling medical marijuana in accordance with state law, there are no federal restrictions on workplace policies concerning medical marijuana use. An employer’s right to enforce a drug-free workplace policy is left for the individual states to decide. So far, only a few states (including Arizona, Delaware and Minnesota) have statutes that prohibit employers from firing workers for a positive marijuana drug test if the employee holds a valid medical marijuana card; and in states without such prohibitions, the courts have generally ruled in favor of the employer. (1) Furthermore, because the federal government still classifies marijuana as a Schedule I drug, it must be treated as a prohibited substance in any workplace that is subject to federal regulations requiring drug testing of safety-sensitive workers or that receives federal funding. (2)

Novus previously analyzed the broader issue of substance abuse among American workers and found that drug use had a negative effect on employee productivity. Several studies have specifically explored the impact of marijuana use among workers and reported similar findings. One study noted that smoking cannabis impairs performance for a period of about four hours and presents an increased risk for injury or accidents when used before work or on the job. (3) Another study examined postal workers who tested positive for marijuana on a pre-employment drug test and found that they had 55% more industrial accidents, 85% more injuries and a 78% increase in absenteeism compared to workers who tested negative for marijuana use. (4)

“Given that marijuana has been shown to have a negative impact on job performance and safety, employers have a legitimate concern regarding its use in the workplace,” said Will Wesch, Director of Admissions for Novus Medical Detox Center. “Businesses still maintain the right to conduct drug testing among workers and job candidates. And while a few states offer protections for people who hold a valid medical marijuana prescription, the majority of states do not. This means employers may terminate employment or rescind job offers for anyone who tests positive for marijuana use, and legal precedent has been on the employers’ side.”

According to the U.S. Drug Enforcement Administration, marijuana’s classification as a Schedule I substance means that it has “a high potential for abuse and potentially severe psychological and/or physical dependence.” (5) Wesch cautions that this potential for addiction may result in marijuana serving as a gateway to harder drugs: “Many people dismiss marijuana as a ‘soft drug’ and don’t see the harm in using it. But among the patients admitted to Novus for substance abuse treatment and detox, we’ve found that an overwhelming percentage of them started out using marijuana before graduating to cocaine, heroin, opiates or other illicit drugs.”

Wesch advises workers to be aware that marijuana use can jeopardize their employment, health and safety, and urges them to proceed with caution even in states when medical marijuana is legally permitted. For those using cannabis in addition to other prescription medications or illicit drugs, Novus offers customized substance abuse treatment programs that can help individuals overcome dependency and addiction. The Florida drug detox facility features a home-like residential setting, medically supervised care and a personalized treatment program that is designed to minimize the discomfort of withdrawal and contribute to a successful recovery.

For more information on Novus Medical Detox Center and its substance abuse treatment programs, visit http://www.novusdetox.com.

About Novus Medical Detox Center:

Novus Medical Detox Center is a Joint Commission Accredited inpatient medical detox facility that offers safe, effective alcohol and drug treatment programs in a home-like residential setting. Located on 3.25 tree-lined acres in New Port Richey, Fla., Novus is also licensed by the Florida Department of Children and Families and is known for minimizing the discomfort of withdrawal from prescription medication, drugs or alcohol by creating a customized detox program for each patient. By incorporating medication, natural supplements and fluid replenishment, Novus tailors the detox process for each patient, putting the dignity and humanity back into drug detoxification. Patients have 24/7 medical supervision, including round-the-clock nursing care and access to a withdrawal specialist, and enjoy comfortable private or shared rooms with a telephone, cable television and high-speed Internet access. Novus’ expansion is tied to their contribution to their industry and their local community, ranking number 48 on the Tampa Bay Business Journal’s 2014 Fast 50 Awards list of the fastest-growing companies in Tampa Bay, and number 2,936 on the 2014 Inc. 500/5000 list of fastest-growing companies in America. For more information, visit http://www.novusdetox.com.
1. Rojas, Jasmin. “Marijuana and the Workplace. What’s an Employer to Do?”; HR and Employment Law News on HR.BLR.com; January 21, 2015. hr.blr.com/HR-news/Performance-Termination/Alcohol-and-Drugs-Testing/Marijuana-and-workplace-Whats-an-employer-to-do#

2. Becker, Jamie. “The State of Marijuana in the U.S. in 2015”; Lifelines; February 2015. lhsfna.org/index.cfm/lifelines/february-2015/the-state-of-marijuana-in-the-u-s-in-2015/

3. Macdonald, Scott; Wayne Hall; et al. “Testing for Cannabis in the Work-Place: A Review of the Evidence”; Addiction; March 2010. onlinelibrary.wiley.com/doi/10.1111/j.1360-0443.2009.02808.x/abstract

4. Zwerling, Craig; James Ryan; and Endel John Orav. “The Efficacy of Preemployment Drug Screening for Marijuana and Cocaine in Predicting Employment Outcome”; JAMA; November 28, 1990. jama.jamanetwork.com/article.aspx?articleid=384067

5. U.S. Drug Enforcement Administration. Drug Schedules; no date; accessed February 16, 2015. dea.gov/druginfo/ds.shtml

Karla Jo Helms, JoTo PR, +1 (888) 202-4614 Ext: 802, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.